Literature DB >> 30747022

High diagnostic yield and novel variants in very late-onset spasticity.

Momen Almomen1, Kristina Martens2, Asfia Quadir2, Carly Sabine Pontifex2, Alexandra Hanson3, Lawrence Korngut2,3, Gerald Pfeffer2,3.   

Abstract

Hereditary spastic paraplegias (HSPs) are a diverse group of genetic conditions with variable severity and onset age. From a neurogenetic clinic, we identified 14 patients with very late-onset HSP, with symptoms starting after the age of 35. In this cohort, sequencing of known genetic causes was performed using clinically available HSP sequencing panels. We identified 4 patients with mutations in SPG7 and 3 patients with SPAST mutations, representing 50% of the cohort and indicating a very high diagnostic yield. In the SPG7 group, we identified novel variants in two patients. We have also identified two novel mutations in the SPAST group. We present sequencing data from cDNA and RT-qPCR to support the pathogenicity of these variants, and provide observations regarding the poor genotype-phenotype correlation in these conditions that should be the subject of future study.

Entities:  

Keywords:  hereditary spastic paraplegia; late-onset; paraplegin; primary lateral sclerosis

Mesh:

Substances:

Year:  2019        PMID: 30747022     DOI: 10.1080/01677063.2019.1566326

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  2 in total

1.  Case Report: Calpainopathy Presenting After Bone Marrow Transplantation, With Studies of Donor Genetic Content in Various Tissue Types.

Authors:  Kristina Martens; Jamie Leckie; Daniel Fok; Robyn A Wells; Sameer Chhibber; Gerald Pfeffer
Journal:  Front Neurol       Date:  2021-01-11       Impact factor: 4.003

Review 2.  The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1).

Authors:  Michelle A Johnson; Jacob A Klickstein; Richa Khanna; Yunzi Gou; Malavika Raman
Journal:  Neurobiol Dis       Date:  2022-04-08       Impact factor: 7.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.